Pharmacology of natural bioactive compounds used for management of Huntington diseases: An overview
Dipak Dilipkumar Gadade(Ambedkar University Delhi), Nagendra Singh Chauhan(Government Ayurved College, Nanded), Rashmi Sareen(Ambedkar University Delhi), Kamal Shah(GLA University), Vimal Kumar(Maharaja Sayajirao University of Baroda), Anuj Modi(Ambedkar University Delhi), Nitin Jain(Parul University)
Cited by 2
Related Papers
Ibrutinib and Venetoclax for First-Line Treatment of CLL
|New England Journal of Medicine|2019|502
Clinical experience with the <scp>BCL</scp>2‐inhibitor venetoclax in combination therapy for relapsed and refractory acute myeloid leukemia and related myeloid malignancies
|American Journal of Hematology|2017|437
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
|The Lancet|2020|366
Phyllanthus amarus: Ethnomedicinal uses, phytochemistry and pharmacology: A review
|Journal of Ethnopharmacology|2011|365